Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A comparison of the effects of adrenaline and noradrenaline in critically ill patients
ISRCTN ISRCTN92846592
ClinicalTrials.gov identifier
Public title A comparison of the effects of adrenaline and noradrenaline in critically ill patients
Scientific title
Acronym The Cat study
Serial number at source N/A
Study hypothesis The aim of the Cat study is to compare the clinical effects of adrenaline and noradrenaline in critically ill patients with circulatory dysfunction or failure. It is a prospective, double blind, randomised trial. Patients will be designated a priori into two groups: circulatory failure due to sepsis syndrome/septic shock and circulatory failure due to non-septic causes (cardiogenic shock, normovolaemic hypotension, augmentation of mean arterial pressure). The null hypothesis assumes no difference in resolution of circulatory failure or all-cause mortality in patients with circulatory failure receiving infusions of either adrenaline or noradrenaline.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Australia
Disease/condition/study domain Circulatory failure in critically ill patients
Participants - inclusion criteria Critically ill patients requiring a catacholamine infusion for cardiovascular support
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/10/2003
Anticipated end date 31/10/2005
Status of trial Completed
Patient information material
Target number of participants 250
Interventions Patients randomised to receive either adrenaline or noradrenaline
Primary outcome measure(s) Time to resolution of circulatory failure to pre-morbid state from commencement of catecholamine.
Secondary outcome measure(s) ICU length of stay and mortality, hospital mortality and 90-day mortality: degree of organ dysfunction during 28-day period (as determined by SOFA scores): cardiovascular, respiratory, renal, neurological, hepatic; and metabolic function.
Sources of funding Not provided at time of registration
Trial website
Publications 2008 results on http://www.ncbi.nlm.nih.gov/pubmed/18654759
Contact name Dr  John  Myburgh
  Address Intensive Care Unit
The St George Hospital
Gray Street
  City/town Kogarah, Sydney
  Zip/Postcode 2217
  Country Australia
Sponsor The St George Hospital - Dept of Intensive Care (Australia)
  Address Gray Street
  City/town Kogarah, Sydney
  Zip/Postcode 2217
  Country Australia
Date applied 12/11/2004
Last edited 30/10/2008
Date ISRCTN assigned 07/03/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central